Eva Wang, PhD, MBA

Eva Wang, PhD, MBA has accumulated significant work experience in the field of biotechnology and computational technology. Eva'smost recent position is as the Chief Technology Officer (CTO) at Active Motif, a role they started in December 2021. Prior to this, they worked as a Startup Advisor and Angel Investor for various companies including PreCyte, Sentrix, Immunis, Arima, and Nudj Health starting in January 2015.

From January 2020 to December 2021, Eva served as the Vice President of Research and Development (R&D) at Epic Sciences, where they were responsible for building and scaling up genomics capabilities, developing liquid biopsy assays, and overseeing informatics software and computational capabilities.

Before their role at Epic Sciences, Eva worked as the Bioinformatics Director at the Gladstone Institutes from 2016 to January 2020. Eva also held the position of Head of Program Management, Bioinformatics/Biostatistics and Information Systems at HTG Molecular Diagnostics from July 2012 to 2016.

Earlier in their career, Eva was the Senior Director of Software/IT and Biostatistics/Bioinformatics at CareDx, Inc. from May 2011 to June 2012, and the Director of Data Analysis and Algorithm Development at Veracyte, Inc. from April 2008 to April 2011. Eva started their professional journey as a Senior Scientist at Affymetrix in September 2000.

Overall, Eva Wang's work experience has been characterized by leadership roles in research and development, bioinformatics, and computational technology within the biotech industry.

Eva Wang, PhD, MBA has a diverse education history. Eva completed their Bachelor of Science degree in Microbiology and Immunology at Shandong University. Following this, Eva pursued a PhD in Computer Science with a specialization in Machine Learning and Bioinformatics at the University of California, Santa Cruz. Eva then furthered their academic accomplishments by earning an MBA at The Wharton School.